Genetic studies in Alzheimer's disease with an NACP/α-synuclein polymorphism

Annals of Neurology

Volumn 40, Issue 2, 1996, Pages 207-215

  Xia, Yu ^a,d   De Rohan Suva, H A ^a   Rosi, Barbara L ^b   Yamaoka, Larry H ^c   Rimmler, Jacqueline B ^d   Pericak Vance, Margaret A ^a   Roses, Allen D ^b   Chen, Xiaohua ^c   Masliah, Eliezer ^d   Deteresa, Richard ^d   Iwai, Akihiko ^a   Sundsmo, Mary ^b   Thomas, Ronald G ^c   Richard Hofstetter, C ^a   Gregory, Ethan ^b   Hansen, Lawrence A ^a   Katzman, Robert ^b   Thai, Leon J ^b   Saitoh, Tsunao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Charring Cross and Westminster Medical School   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; APOLIPOPROTEIN E; DINUCLEOTIDE; DNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC LINKAGE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 9444298408     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400212     Document Type: Article

References (32)

1. Uéda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sei USA 1993:90:11282-11286
2. Chen X, de Suva HAR, Pettenati MJ, et al. The human NACP/Ct-synucIein gene: chromosome assignment of 4q21.3-q22 and Taql RFLP analysis. Genomics 1995:26:425-427
3. Jakes R, Spillantini MG, Goedert M. Identification of t\vo distinct synucleins from human brain. FEES Lett 1994:345:27-32
4. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system. Neuron 1995:14:467-475
5. Iwai A, Yoshimoto M, Masliah E, Saitoh T. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 1995:34:10139-10145
6. Han H, Weinreb PH, Landsbury PTJ. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol 1995:2:163-169
7. Yoshimoto M, Iwai A, Kang D, et al. NACP, the precursor protein of non-Aβ component of Alzheimer's disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc Natl Acad Sei USA 1995:92:9141-9145
8. Corder EH, Saunders AM, Strittmatter \VJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993:261:921-923
9. Saunders AM, Strittmatter \VJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993:43:1467-1472
10. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994:7:180-184
11. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work groups under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984:34:939-944
12. Katzman R, Brown T, Thal LJ, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol 1988;24: 384-389
13. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985:42:1097-1105
14. Pericak-Vance MA, Yamaoka LH, Haynes CS, et al. Genetic linkage studies in Alzheimer's disease families. Exp Neurol 1988:102:271-279
15. Pericak-Vance MA, Bebout JL, Gaskel PC Jr, et al. Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991:48:1034-1050
16. Saunders AM, Schmader K, Breitner JC, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993:342:710-711
17. Dausett J, Cann H, Cohen D, et al. Centre d'Etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990:6:575-577
18. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989
19. Lathrop GM, Lalouel JM. Easy calculation of lod scores and genetic risks on small computers. Am J Hum Genet 1984;36: 460-465
20. Lathrop GM, Lalouel JM. Efficiency of recombination estimates using two- and three-point linkage data. Prog Clin Biol Res 1985:194:97-102
21. Weeks DE, Lange K. The afFected-pedigree-member method of linkage analysis. Am J Hum Genet 1988:42:315-326
22. Wenham PR, Price WH, Blundell G. Apolipoprotein E typing by one-stage PCR. Lancet 1991:337:1158-1159
23. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res 1991:31:545-548
24. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sei USA 1993:90:1977-1981
25. Wisniewski T, Golabek A, Matsubara E, et al. Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 1993:192:359-365
26. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994:372:92-94
27. Sanan DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform ApoE4 associates more efficiently than ApoE3. J Clin Invest 1994:94:860-869
28. Schmechel DE, Saunders AM, Strittmatter \VJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onser Alzheimer disease. Proc Natl Acad Sei USA 1993:90:9649-9653
29. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993:11:575-580
30. Masliah E, Iwai A, Mallory M, et al. Altered presynaptic protein NACP is associated with plaque formation in Alzheimer's disease. Am J Pathol 1996 (in press)
31. Campion D, Martin C, Heilig R, et al. The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer's disease. Genomics 1995:26:254-257
32. Uéda K, Saitoh T, Mori H. Tissue-dependent alternative splicing of mRNA for NACP, the precursor non-Aβ component of Alzheimer's disease amyloid. Biochem Biophys Res Commun 1994:205:1366-1372